Navigation Links

Biology Technology

Opal Kelly Announces ZEM5310 with Altera Cyclone V E and FrontPanel SDK

Portland, OR (PRWEB) January 18, 2017 Opal Kelly, a leading producer of powerful FPGA modules that provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 interface and an Altera Cyclone V E FPGA int... [Comments]

In situ Hybridization Market Worth 739.9 Million USD by 2021

PUNE, India , January 18, 2017 According to a new market research report "In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to 2021" published by MarketsandMarkets, the market is expected to... [Comments]

Boston Biomedical to Highlight Data for Cancer Stemness Inhibitor Napabucasin in Patients with Colorectal Cancer at 2017 ASCO GI

CAMBRIDGE, Mass. , Jan. 18, 2017   Boston Biomedical , an industry leader in the development of novel compounds designed to target cancer stemness pathways, will feature data from two clinical studies for its lead investigational compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held from January 19-21, in San Francisco . Napabucasin is an o... [Comments]

Applied BioMath, LLC to present at Boston Area Group for Informatics and Modeling Meeting

LINCOLN, Mass. , Jan. 18, 2017 Applied BioMath ( ), the industry-leader in applying mechanistic modeling to drug research and development, today announced that Dr. John Burke , PhD, Co-Founder, President, and CEO of Applied BioMath, will present at the next Boston Area Group for Informatics and Modeling (BAGIM) Meeting on Thursday January 19, 2017 at th... [Comments]

Parent Project Muscular Dystrophy Awards NJIT and Talem Technologies a $600,000 Grant to Continue Exploration of an Upper Extremity Exoskeleton in Duchenne Muscular Dystrophy

HACKENSACK, N.J. , Jan. 18, 2017   Parent Project Muscular Dystrophy (PPMD) , a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) , today announced a $600,000 grant to be awarded to the New Jersey Institute of Technology (NJIT) and Talem Technologies (Talem) as part of the organization's ongoing exploration of robotic techn... [Comments]

Slone Partners Sponsors the SCOPE Summit for Clinical Ops Executives 2017

(PRWEB) January 18, 2017 Executive search firm Slone Partners proudly supports the SCOPE Summit for Clinical Ops Executives 2017 in its continued commitment to the advancement of the clinical trials segment. Hosted in Miami, this conference brings together renowned decision makers to discuss... [Comments]

SpineFrontier Announces Increasing Adoption of Its A-CIFT™ Solofuse-P Standalone Cervical Interbody by Younger Surgeons Like Dr. Dante Leven

Malden, MA (PRWEB) January 18, 2017 Total Orthopedics and Sports Medicine ( ) announced today that Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January 11, 2017 at Long Island Jewish, Vall... [Comments]

Whitehouse Labs Increases Focus and Expertise In Extractables & Leachables

Whitehouse, NJ (PRWEB) January 18, 2017 Whitehouse Labs has furthered its efforts towards gaining access to more and more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables & Impurities has more than doubled in the... [Comments]

RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network

Frederick, Maryland (PRWEB) January 18, 2017 Announced in December 2016, RoosterBio is now part of two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker has announced the award of a new National Institute for Innovation in Ma... [Comments]

MYOLYN Submits Application for FDA Clearance of its MyoCycle Device

Gainesville, FL (PRWEB) January 18, 2017 MYOLYN, which creates medical technology for people with muscle weakness and paralysis, today announced that it has submitted a 510(k) to the FDA, requesting clearance of the MyoCycle Home and the MyoCycle Pro – stationary bikes that utilize MYOLYN’s p... [Comments]

Study Suggests Improved Method For Pinpointing If Prostate Cancer Will Return - Dr. David Samadi Investigates

New York, NY (PRWEB) January 18, 2017 Researchers from a new study are stating that if levels of the blood test called prostate specific antigen (PSA) do not fall low enough after prostate cancer treatment, this indicates there is still remaining prostate cancer cells that are more likely t... [Comments]

Medicine Technology

EnteroMedics Announces Pricing of $16.5 Million Underwritten Public Offering

SAINT PAUL, Minn. , Jan. 18, 2017  EnteroMedics Inc. (NASDAQ: ETRM ), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the pricing of an underwritten public offering of units for gross proceeds of $16.5 million, prior to deducting underwriting discounts an... [Comments]

Aprima Medical Software Acquires EHR Reseller Healthcare Data Solutions

DALLAS , Jan. 18, 2017  Aprima Medical Software, a leading provider of innovative electronic health records (EHR), practice management (PM) and revenue cycle management (RCM) solutions for medical practices, today announced the acquisition of a former reseller Healthcare Data Solutions (HDS) of Coral Cables, FL. As part of the agreement, Aprima will assume full support for... [Comments]

Breast Imaging Technologies Market is Expected to Reach $4,502 Million by 2022, Globally - Allied Market Research

PORTLAND, Oregon and PUNE, India , January 18, 2017 A new report published by Allied Market Research, titled, "Breast Imaging Technologies Market by Type: Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that the global breast imaging technologies market size was valued at $2,544 million in 2015 and is expected to reach $4,502 million by 2022, grow... [Comments]

Global Vital Signs Monitoring Devices Market Opportunity Analysis and Industry Forecast, 2022: BP Monitoring Devices Accounted More Than Half of the $3.69 Billion Market - Research and Markets

DUBLIN , Jan 18, 2017 Research and Markets has announced the addition of the "Vital Signs Monitoring Devices Market by Product, by End User - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering. Vital signs monitoring market size was worth $3,694 million in 2015 and is expected to reach $5,491 million by 2022, growing... [Comments]

Three Companies Receive Seed Funds to Develop Medical Devices for Children

PHILADELPHIA , Jan. 18, 2017 The Philadelphia Pediatric Medical Device Consortium (PPDC) has announced seed grants to three companies developing medical devices for children. The Consortium chose those companies from eight finalists in a competition to receive seed grants of $50,000 each. The devices under development are a powered orthotic arm brace that amplif... [Comments]

Hyatt Place Nashville/Downtown and Adaptive Sound Technologies Partner to Deliver Great Night's Sleep

SAN JOSE, Calif. , Jan. 18, 2017  Adaptive Sound Technologies, Inc. (ASTI), the leading supplier of sound machines, announced today a new partnership with Hyatt Place Nashville/Downtown to deliver the best sleep experience for its guests by providing ASTI LectroFan sleep therapy machines in over two hundred of its guest rooms. "Obviously one of the most important pa... [Comments]

Spotlight Innovation Subsidiary Caretta Therapeutics Announces Venodol, a New Over-the-counter Product to Treat Chronic Pain

URBANDALE, Iowa , Jan. 18, 2017   Spotlight Innovation Inc. (OTCQB: STLT) today announced that subsidiary Caretta Therapeutics plans, in the second quarter of 2017, to launch its first product. Venodol, a topical roll-on intended to provide relief from chronic pain, is a non-addictive alternative to opioid and steroidal analgesics. It was developed under a licensing agree... [Comments]

Regenicin Reports 2016 Operating Results, Outlines Milestones for 2017

LITTLE FALLS, N.J. , Jan. 18, 2017   Regenicin, Inc. (OTC Bulletin Board: RGIN ), a biotechnology company specializing in the development and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, recently reported the Company's operating results for 2016 and an outline of key milestones for 2017. As the Company described... [Comments]

PinneyAssociates' Scientific Abuse Potential Assessment of Kratom Finds Evidence of Public Health Benefit and Little Harm

BETHESDA, Md. , Jan. 18, 2017  Kratom leaves, from a South East Asian tree in the coffee family, are often used to prepare tea-like beverages and commercially manufactured products which are consumed by several million Americans annually to increase alertness, enhance well-being and occupational performance, and as a natural remedy for minor aches and pains. PinneyAssociat... [Comments]

Polyphenol Market to Reach $1,127 Million by 2022, Globally - Allied Market Research

PORTLAND, Oregon and PUNE, India , January 18, 2017 According to a new report published by Allied Market Research, titled, "Polyphenol Market by Product Type and by Application: Global Opportunity Analysis and Industry Forecast, 2014 - 2022," the global polyphenol market was valued at $757 million in 2015, and is expected to reach $1,127 million by 2022, growing at a CAG... [Comments]

Dermata Therapeutics, LLC Announces Initiation of Treatment in a Phase 2 Acne Rosacea Clinical Study

SAN DIEGO , Jan. 18, 2017  Dermata Therapeutics, LLC, a biotechnology company developing new and innovative products to treat a variety of dermatological diseases, announces dosing the first patient with its lead compound DMT210, in a Phase 2 acne rosacea study. DMT210 is a topical gel specifically developed to downregulate the proinflammatory cytokines in the skin respons... [Comments]

(Date:1/17/2017)... Point, IA (PRWEB) , ... January 17, 2017 ... ... from China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance System ... to glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean herbicide. ...
(Date:1/17/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... earnings conference call will be broadcast live over the ... Eastern Time.  A news release detailing the quarterly and ... Eastern Time the morning of the conference call. ... Zimmer Biomet,s Investor Relations website at . ...
(Date:1/17/2017)... , Jan. 17, 2017  Only nine percent ... patients over profits, while only 16 percent believe health ... released today. Meanwhile, 36 percent of U.S. adults believe ... patients over profits, compared to hospitals (23%). ... maelstrom," said Wendy Salomon , vice president of ...
(Date:1/17/2017)... Boston, MA (PRWEB) , ... January 17, 2017 ... ... of the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment ... be validating these new tools and assays, and their applicability in drug safety ...
Breaking Biology Technology:
(Date:1/18/2017)... URBANDALE, Iowa , Jan. 18, 2017 /PRNewswire/ ... announced that subsidiary Caretta Therapeutics plans, in the ... product. Venodol, a topical roll-on intended to provide ... to opioid and steroidal analgesics. It was developed ... Reid to commercialize products derived from snake ...
(Date:1/18/2017)... Research and Markets has announced the addition of the "Global ... offering. ... global CINV drugs market to grow at a CAGR of 5.41% ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. To calculate the market ...
(Date:1/18/2017)... 2017 In China , we ... the Upgrade of China,s Healthy Strategy ... Plan for Economic and Social Development of the ... and the state council of the People,s Republic ... emerging industry development plan, identifying medical devices as one of ...
Breaking Medicine Technology: